SlideShare a Scribd company logo
LUNG VOLUMES
&CAPACITIES
BEDSIDE PULMONARY
FUNCTION TESTS
• Lung volumes and lung capacities refer to volume of
air associated with different phases of the respiratory
cycle.
• Lung volumes are directly measured.
• Lung capacities are inferred from lung volumes.
• John Hutchinson invented spirometer.
• Cant Measure –FRC,RV,TLC
18/7/2021 Dr.K.Ha
ritha
2
LUNG VOLUMES
18/7/2021 Dr.K.Ha
ritha
3
• 1.Tidal volume
• 2.Inspiratory reserve volume
• 3.Expiratory reserve volume
• 4.Residual volume
• TIDAL VOLUME
• Normal volume of air inspired or expired during quiet
breathing
• Normal volume:500ml
• RESIDUAL VOLUME:
• Volume remaining in the lung after a maximal expiratory
effort
• Normal value:1200ml
18/7/2021 Dr.K.Ha
ritha
4
• INSPIRATORY RESERVE VOLUME:
• Volume of air that can be inspired with maximal effort
above the normal resting end expiratory position of a tidal
volume.
• Normal value:3000ml in adult male
• EXPIRATORY RESERVE VOLUME:
• Volume of air that can be forcibly exhaled between resting
end expiratory volume and RV.
• Normal value:1100ml
CAPACITIES
• VITAL CAPACITY:
• amount of air that can be exhaled from the point of
maximal inspiration to the point of maximal
expiration (IRV+TV+ERV).
• FORCED VITAL CAPACITY:
• Volume of air that can be exhaled with maximal
effort from total lung capacity
5
• TOTAL LUNG CAPACITY(TLC):
• Total volume of air in the lungs after a maximal
inspiration
• IRV+TV+ERV+RV
• FRC-FUNCTIONAL RESIDUAL CAPACITY
• Amount of air in the lung at the end of quiet
exhalation.
• ERV+RV
FUNCTIONAL RESIDUAL
CAPACITY
INCREASED DECREASED
1)Height 1) upright to supine(1 L)
2)Age
2)Inductionanaesthesia0.5L
20%
3)Fibrotic lung diseases
4)women
5)obesity
Dr.K.Ha
ritha
6
• Closing Capacity:
 CC is the sum of closing volume (CV) and
RV.
 Measurement is by wash in technique with a
small bolus of insoluble tracer gas xenon or by
nitrogen washout after inspiration of a breath of
oxygen from RV.
 Normal value-15% to 20% of VC
 Increases with age due to loss of structural
parenchymal support tissue in the lung and
increase in RV.
Closing volume:
 CV is the lung volume below which small airways
begin to close (or at least cease to contribute
expiratory gas) during expiration.
 Closure of small airways in the basal portions of the
lung during deep expiration is a normal phenomenon
due to the gravity-dependent increase in pleural
pressure at the bases and due to lack of
parenchymal support in distal airways.
SPIROMETRYPREREQUISITES
Do not smoke for at
least1hourbefore the
test.
Do not drink alcohol for at
least 4 hours before the test.
Do not exercise heavily for at
least 30 minutes before the
test.
Do not wear tight clothing
that makes it difficult for you
to take a deep breath.
Do not eat a large meal
within 2 hours before the test.
ACCEPTABILITY CRITERIA
Good start of test- without any hesitation
No Artifact (coughing / glottis closure)
 No variable flow
 No early termination(> 6 sec)
 No air leak
REPEATABILITY CRITERIA
Two largest FVC within 150 ml of each
other
Upto 8 manoeuver can be repeated
till criteria are met
MEASURING FRC ANDRV
18/7/2021 Dr.K.Ha
ritha
10
1) N2 WashoutTechnique:
patient breathes 100%
oxygen
all the nitrogen in the lungs is washed
out
exhaled volume and the
nitrogen concentration are
measured.
nitrogen volume at
the initial concentration
final exhaled FRC
concentration
2)HeliumDilutiontechnique:
Pt breathes in and out from a reservoir
with known volume of gas containing
trace of helium.
Helium gets diluted by gas previously
present in lungs.
3)BodyPlethysmography
Plethysmography (derived from greek
word meaning enlargement). Based on
principle of BOYLE’S LAW(PV=k)
A patient is placed in a sitting position
in a closed body box with a known
volume
The patient pants with an open glottis
against a closed shutter to produce
changes in the box pressure
proportionate to the volume of air in the
chest.
As measurements done at
end of expiration, it yields FRC
14
Forced expiratory volume in 1 sec (FEV1): Volume of air
that can be forcefully exhaled in 1 sec. Values between 80%
and 120% of the predicted value are considered normal.
Forced vital capacity (FVC): The volume of air that can be
exhaled with maximum effort after a deep inhalation. Normal
values are 3.7 L in females and 4.8 L in males. Ratio of
FEV1 to FVC: This ratio in healthy adults is 75%–80%.
Forced expiratory flow at 25%–75% of vital capacity
(FEF25%– 75%): A measurement of airflow through the
midpoint of a forced exhalation.
Maximum voluntary ventilation (MVV): The maximum
amount of air that can be inhaled and exhaled within 1
min.
• The volume is measured over a 15-sec time period
and results are extrapolated to obtain a value for 1
min expressed as liters per minute.
• Average values for males and females are 140–180
and 80–120 L/min, respectively
. Diffusing capacity (Dlco):
• The volume of a substance [CO] transferred
across the alveoli into blood per minute per unit
of alveolar partial pressure.
• CO is rapidly taken up by hemoglobin and Its
transfer is therefore limited mainly by diffusion.
• A single breath of 0.3% CO and 10% helium is
held for 20 sec. Expired partial pressure of CO
is measured.
• Normal value is 17–25 mL/min/mm Hg.
OBSTRUCTIVE PATTERN
Common obstructive lung diseases;
 Asthma
 COPD (chronic bronchitis, emphysema)
RESTRICTIVE PATTERN
 Characterized by reduced lung
volumes/decreased lung compliance
Examples:
Interstitial Fibrosis
Scoliosis
Obesity
Lung Resection
Neuromuscular diseases
FEV1 FVC FEV1/FVC
OBSTRUCTIVE DECREASED
(<80%)
DECREASED DECREASED(< 0.7)
RESTRICTIVE DECREASED DECREASED NORMAL OR INCREASED
1) FORCED VITAL CAPACITY
Maximum volume of air that can be breathed out
as forcefully and rapidly as possible following a
maximum inspiration.
The expiration should be at least 4 seconds and
should not be interrupted by coughing, glottis
closure or mechanical obstruction.
Normal healthy subjects have VC = FVC.
Indirectly reflects flow resistance property of
airways.
Interpretation of % predicted:
>80-120% Normal
70-79% Mild reduction
50%-69% Moderate reduction
<50% Severe reduction
2) FORCED EXPIRATORY VOLUME in 1 SEC.
(FEV1)
Forced expired volume in 1 sec during
FVC maneuver.
Expressed as an absolute value or % of
FVC
Normal - FEV1 (1 SEC)- 75-85% OF FVC
FEV2 (2 SEC)- 94% OF FVC
FEV3 (3 SEC)- 97% OF FVC
FEV1 – Decreased in both obstructive &
restrictive lung disorders
 FEV1%=FEV1/VC X100.
• FEV1/FVC – Reduced in obstructive
disorders.
Interpretation of FEV1 % predicted:
>80% Normal
50%-80% Mild obstruction
30%-50% Moderate
<30% Severe
A FEV1% that is too high is suggestive for a
restriction of the pulmonary volume.
PULMONARY
FUNCTION TESTS
Indicate group of studies or maneuvers
performed using standardized equipment
to measure lung function
 Evaluate one or more aspects of the
respiratory system
Respiratory mechanics
Lung parenchymal function/ Gas
exchange
Cardiopulmonary interaction
15
INDICATIONS
Investigation of patients with symptoms/signs/
investigations that suggest pulmonary disease
e.g.(Cough/Wheeze/Breathlessness/Crackles)
Monitoring patients with known pulmonary
disease for progression and response to
treatment e.g.
• Interstitial fibrosis
• COPD & Asthma
• Pulmonary vascular disease
Investigationof patients with disease that may
have a respiratory complications e.g.
• Connective tissue disorders
• Neuromuscular diseases
Preoperative evaluation prior to
• Lung resection
• Abdominal surgery
• Cardiothoracic surgery
• Evaluation of patients at risk of lungdiseases
• Exposure to pulmonary toxins such as
radiation,medication,environmental,occupational,
exposure
• Surveillance following lung transplantation to
assess for
• 1)Acute rejection
• 2)Infection
• 3)Obliterative bronchiolitis
CONTRAINDICATIONS
• Myocardial infarction with in last month
• Unstable angina
• Recent thoracoabdominal surgery
• Recent ophthalmic surgery
• Thoracic or abdominal aneurysm
• H/o syncope with forced exhalation
• Current pneumothorax/hemoptysis
INDICATIONS OF PFT IN PAC
TISI GUIDELINES FOR PREOPERATIVE
SPIROMETRY
Age > 70 yrs.
Morbid obesity
Thoracic surgery
Upper abdominal surgery
Smoking history and cough
Any pulmonary disease
American College Of Physicians
(ACP) Guidelines For
Preoperative Spirometry
Lung resection
H/o smoking, dyspnoea
Cardiac surgery
Upper abdominal surgery
Lower abdominal surgery
Uncharacterized pulmonary
disease (defined as history of
pulmonary Disease or symptoms
and no PFT in last 60 days)
Bed sidepulmonary
function tests
1) SABRASEZ BREATHHOLDING
TEST:
Ask the patient to take a full but not too deep breath &
hold it as long as possible.
Assessment of cardio pulmonary reserve
>25 SEC - NORMAL Cardiopulmonary Reserve
(CPR)
15-25 SEC - LIMITED CPR
<15 SEC - VERY POOR CPR (Contraindication for
elective surgery)
2) SCHNEIDER’S MATCH BLOWING
TEST:Ability of patient to cough &bring out secretions in post
operative period or reduction in post op atelectasis
Measures Maximum Breathing Capacity
Ask to blow a match stick from a distance of 6” (15
cms) with-
 Mouth wide open
 Chin rested/supported
 No purse lipping
 No head movement
 No air movement in the room
 Mouth and match at the samelevel
18/7/2021 Dr.K.Ha
ritha
25
Can’t blow
out
Able to
blow
MBC < 60 L/min
FEV1 < 1.6L
Modified match test:
DISTANCE
9”
6”
3”
MBC > 60L/min
FEV1>1.6L
MBC
>150 L/MIN.
>60 L/MIN.
>40 L/MIN
3.COUGH TEST
Deep breath inadequate cough if:
Followed by cough FVC<20 ml/kg
• Ability to cough FEV1<15 ml/kg
• Strength PEFR<200L/min
• Effectiveness VC-3 Times TV for
effective cough
4) FORCED EXPIRATORYTIME:
After deep breath, exhale maximally and
forcefully & keep stethoscope over
trachea& listen.
Normal FET – 3-5 SECS.
OBS.LUNG DIS. - > 6 SEC
RES. LUNG DIS.- < 3 SEC
28
18/7/2021 Dr.K.Ha
ritha
29
5)SINGLE BREATHCOUNT:
After deep breath, hold it and start
counting till the nextbreath.
N- 30-40 COUNT
Indicates vital capacity
6) WRIGHT PEAK FLOW METER:
Measures Peak Expiratory Flow Rate
(PEFR)
• Normal – males- 450-700
l/min.
females- 350-500 l/min.
7) DE-BONO WHISTLE BLOWING
TEST:
Measures PEFR.
Patient blows down a wide
bore tube
whistle blows
leak hole is gradually increased till the
till the intensityof whistle disappears.
The last position at which the whistle can be blown
the PEFR can be read off the scale.
,
8) WRIGHT RESPIROMETER:
measures TV, MV
 Instrument- compact, light and portable.
Can be connected to endotracheal tube or face
mask
MV- instrument record for 1
min. and read directly
TV-calculated by dividing
MV by counting Respiratory
Rate.
Disadvantage: It under-
reads at low flow rates and
over- reads
at high flow rates.
9)SPHYGMOMANOMETER BLOW
TEST (endurancetest):
-Ask to blow and raise column of Hg
upto 40- 50 mmHg and duration is
noted.
-50 seconds is normal.
10)MICROSPIROMETERS;Measure
VC
11) BED SIDE PULSE OXIMETRY
12) ABG.
REFERENCES;
1).MILLERS ANAESTHESIA
2).STOELTINGS PHYSIOLOGY AND
PHARMACOLOGY
3).STOELTINGS CO-EXISTING DISEASES
34

More Related Content

Similar to lung volumes new v.pptx

Spirometry
SpirometrySpirometry
Spirometry
ArabilReang
 
Pulmonary function testing
Pulmonary function testingPulmonary function testing
Pulmonary function test Dr Kavita.pptx
Pulmonary function test Dr Kavita.pptxPulmonary function test Dr Kavita.pptx
Pulmonary function test Dr Kavita.pptx
KavitaKadyan1
 
Bedside PULMONARY FUNCTION TEST/PFT
Bedside PULMONARY FUNCTION TEST/PFTBedside PULMONARY FUNCTION TEST/PFT
Bedside PULMONARY FUNCTION TEST/PFT
ZIKRULLAH MALLICK
 
spirometry functional lung test
spirometry functional lung test spirometry functional lung test
spirometry functional lung test
Harith Riyadh
 
Anaecon India - Spirometery
Anaecon India - SpirometeryAnaecon India - Spirometery
Anaecon India - Spirometery
Sarthak Jain
 
Pulmonary function tests
Pulmonary function testsPulmonary function tests
Pulmonary function tests
Prasant N
 
Bedside respiratory assessment & spirometry
Bedside respiratory assessment & spirometryBedside respiratory assessment & spirometry
Bedside respiratory assessment & spirometry
Arjun Chhetri
 
Lung volume and capacities 2022.pptx
Lung volume and capacities 2022.pptxLung volume and capacities 2022.pptx
Lung volume and capacities 2022.pptx
shama praveen
 
Pulmonary function tests
Pulmonary function testsPulmonary function tests
Pulmonary function tests
Ranjeet Singha
 
pulmonary function tests
pulmonary function testspulmonary function tests
pulmonary function tests
madhu chaitanya
 
Lung function tests
Lung function testsLung function tests
Lung function tests
deka dada
 
Bedside pft 1
Bedside pft 1Bedside pft 1
Bedside pft 1
DrAnkitPurohit
 
Spirometry
 Spirometry Spirometry
Spirometry
ZIKRULLAH MALLICK
 
Pft
PftPft
Pulmonary Function Tests-Nursing Maseno.pptx
Pulmonary Function Tests-Nursing Maseno.pptxPulmonary Function Tests-Nursing Maseno.pptx
Pulmonary Function Tests-Nursing Maseno.pptx
akoeljames8543
 
pulmonary function test
pulmonary function test pulmonary function test
pulmonary function test
imsurgeon
 
Spirometry
SpirometrySpirometry
Spirometry
schenzker
 
INTERPRETATION OF PFTs.pdf
INTERPRETATION OF PFTs.pdfINTERPRETATION OF PFTs.pdf
INTERPRETATION OF PFTs.pdf
samthamby79
 
Pft
PftPft

Similar to lung volumes new v.pptx (20)

Spirometry
SpirometrySpirometry
Spirometry
 
Pulmonary function testing
Pulmonary function testingPulmonary function testing
Pulmonary function testing
 
Pulmonary function test Dr Kavita.pptx
Pulmonary function test Dr Kavita.pptxPulmonary function test Dr Kavita.pptx
Pulmonary function test Dr Kavita.pptx
 
Bedside PULMONARY FUNCTION TEST/PFT
Bedside PULMONARY FUNCTION TEST/PFTBedside PULMONARY FUNCTION TEST/PFT
Bedside PULMONARY FUNCTION TEST/PFT
 
spirometry functional lung test
spirometry functional lung test spirometry functional lung test
spirometry functional lung test
 
Anaecon India - Spirometery
Anaecon India - SpirometeryAnaecon India - Spirometery
Anaecon India - Spirometery
 
Pulmonary function tests
Pulmonary function testsPulmonary function tests
Pulmonary function tests
 
Bedside respiratory assessment & spirometry
Bedside respiratory assessment & spirometryBedside respiratory assessment & spirometry
Bedside respiratory assessment & spirometry
 
Lung volume and capacities 2022.pptx
Lung volume and capacities 2022.pptxLung volume and capacities 2022.pptx
Lung volume and capacities 2022.pptx
 
Pulmonary function tests
Pulmonary function testsPulmonary function tests
Pulmonary function tests
 
pulmonary function tests
pulmonary function testspulmonary function tests
pulmonary function tests
 
Lung function tests
Lung function testsLung function tests
Lung function tests
 
Bedside pft 1
Bedside pft 1Bedside pft 1
Bedside pft 1
 
Spirometry
 Spirometry Spirometry
Spirometry
 
Pft
PftPft
Pft
 
Pulmonary Function Tests-Nursing Maseno.pptx
Pulmonary Function Tests-Nursing Maseno.pptxPulmonary Function Tests-Nursing Maseno.pptx
Pulmonary Function Tests-Nursing Maseno.pptx
 
pulmonary function test
pulmonary function test pulmonary function test
pulmonary function test
 
Spirometry
SpirometrySpirometry
Spirometry
 
INTERPRETATION OF PFTs.pdf
INTERPRETATION OF PFTs.pdfINTERPRETATION OF PFTs.pdf
INTERPRETATION OF PFTs.pdf
 
Pft
PftPft
Pft
 

More from udayasree30

PTOSIS OF UPPER LID AND MANAGEMENT OF PTOSIS
PTOSIS OF UPPER LID AND MANAGEMENT OF PTOSISPTOSIS OF UPPER LID AND MANAGEMENT OF PTOSIS
PTOSIS OF UPPER LID AND MANAGEMENT OF PTOSIS
udayasree30
 
ANATOMY OF CHOROID.pptx
ANATOMY OF CHOROID.pptxANATOMY OF CHOROID.pptx
ANATOMY OF CHOROID.pptx
udayasree30
 
22-Optic-Disc-Evaluation-IN-Glaucoma.ppt
22-Optic-Disc-Evaluation-IN-Glaucoma.ppt22-Optic-Disc-Evaluation-IN-Glaucoma.ppt
22-Optic-Disc-Evaluation-IN-Glaucoma.ppt
udayasree30
 
anatomyofretina.pptx
anatomyofretina.pptxanatomyofretina.pptx
anatomyofretina.pptx
udayasree30
 
Hypertensive retinopathy.pptx
Hypertensive retinopathy.pptxHypertensive retinopathy.pptx
Hypertensive retinopathy.pptx
udayasree30
 
ULCER.pptx
ULCER.pptxULCER.pptx
ULCER.pptx
udayasree30
 
dry eye.pptx
dry eye.pptxdry eye.pptx
dry eye.pptx
udayasree30
 
ACUTE CONGESTIVE GLAUCOMA.pptx
ACUTE CONGESTIVE GLAUCOMA.pptxACUTE CONGESTIVE GLAUCOMA.pptx
ACUTE CONGESTIVE GLAUCOMA.pptx
udayasree30
 
Pathology of common ocular and orbital tumours.pptx
Pathology of common ocular and orbital tumours.pptxPathology of common ocular and orbital tumours.pptx
Pathology of common ocular and orbital tumours.pptx
udayasree30
 
SUPERIOR OBLIQUE PALSY MANAGEMENT [Autosaved].pptx
SUPERIOR OBLIQUE PALSY MANAGEMENT [Autosaved].pptxSUPERIOR OBLIQUE PALSY MANAGEMENT [Autosaved].pptx
SUPERIOR OBLIQUE PALSY MANAGEMENT [Autosaved].pptx
udayasree30
 
BLINDNESS.pptx
BLINDNESS.pptxBLINDNESS.pptx
BLINDNESS.pptx
udayasree30
 
MYOPIA.pptx
MYOPIA.pptxMYOPIA.pptx
MYOPIA.pptx
udayasree30
 

More from udayasree30 (12)

PTOSIS OF UPPER LID AND MANAGEMENT OF PTOSIS
PTOSIS OF UPPER LID AND MANAGEMENT OF PTOSISPTOSIS OF UPPER LID AND MANAGEMENT OF PTOSIS
PTOSIS OF UPPER LID AND MANAGEMENT OF PTOSIS
 
ANATOMY OF CHOROID.pptx
ANATOMY OF CHOROID.pptxANATOMY OF CHOROID.pptx
ANATOMY OF CHOROID.pptx
 
22-Optic-Disc-Evaluation-IN-Glaucoma.ppt
22-Optic-Disc-Evaluation-IN-Glaucoma.ppt22-Optic-Disc-Evaluation-IN-Glaucoma.ppt
22-Optic-Disc-Evaluation-IN-Glaucoma.ppt
 
anatomyofretina.pptx
anatomyofretina.pptxanatomyofretina.pptx
anatomyofretina.pptx
 
Hypertensive retinopathy.pptx
Hypertensive retinopathy.pptxHypertensive retinopathy.pptx
Hypertensive retinopathy.pptx
 
ULCER.pptx
ULCER.pptxULCER.pptx
ULCER.pptx
 
dry eye.pptx
dry eye.pptxdry eye.pptx
dry eye.pptx
 
ACUTE CONGESTIVE GLAUCOMA.pptx
ACUTE CONGESTIVE GLAUCOMA.pptxACUTE CONGESTIVE GLAUCOMA.pptx
ACUTE CONGESTIVE GLAUCOMA.pptx
 
Pathology of common ocular and orbital tumours.pptx
Pathology of common ocular and orbital tumours.pptxPathology of common ocular and orbital tumours.pptx
Pathology of common ocular and orbital tumours.pptx
 
SUPERIOR OBLIQUE PALSY MANAGEMENT [Autosaved].pptx
SUPERIOR OBLIQUE PALSY MANAGEMENT [Autosaved].pptxSUPERIOR OBLIQUE PALSY MANAGEMENT [Autosaved].pptx
SUPERIOR OBLIQUE PALSY MANAGEMENT [Autosaved].pptx
 
BLINDNESS.pptx
BLINDNESS.pptxBLINDNESS.pptx
BLINDNESS.pptx
 
MYOPIA.pptx
MYOPIA.pptxMYOPIA.pptx
MYOPIA.pptx
 

Recently uploaded

Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loopLOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
debosmitaasanyal1
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Donc Test
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
DIVYANSHU740006
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
Donc Test
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 

Recently uploaded (20)

Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loopLOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 

lung volumes new v.pptx

  • 2. • Lung volumes and lung capacities refer to volume of air associated with different phases of the respiratory cycle. • Lung volumes are directly measured. • Lung capacities are inferred from lung volumes. • John Hutchinson invented spirometer. • Cant Measure –FRC,RV,TLC 18/7/2021 Dr.K.Ha ritha 2
  • 3. LUNG VOLUMES 18/7/2021 Dr.K.Ha ritha 3 • 1.Tidal volume • 2.Inspiratory reserve volume • 3.Expiratory reserve volume • 4.Residual volume
  • 4. • TIDAL VOLUME • Normal volume of air inspired or expired during quiet breathing • Normal volume:500ml • RESIDUAL VOLUME: • Volume remaining in the lung after a maximal expiratory effort • Normal value:1200ml 18/7/2021 Dr.K.Ha ritha 4
  • 5. • INSPIRATORY RESERVE VOLUME: • Volume of air that can be inspired with maximal effort above the normal resting end expiratory position of a tidal volume. • Normal value:3000ml in adult male • EXPIRATORY RESERVE VOLUME: • Volume of air that can be forcibly exhaled between resting end expiratory volume and RV. • Normal value:1100ml
  • 6. CAPACITIES • VITAL CAPACITY: • amount of air that can be exhaled from the point of maximal inspiration to the point of maximal expiration (IRV+TV+ERV). • FORCED VITAL CAPACITY: • Volume of air that can be exhaled with maximal effort from total lung capacity 5
  • 7. • TOTAL LUNG CAPACITY(TLC): • Total volume of air in the lungs after a maximal inspiration • IRV+TV+ERV+RV • FRC-FUNCTIONAL RESIDUAL CAPACITY • Amount of air in the lung at the end of quiet exhalation. • ERV+RV
  • 8. FUNCTIONAL RESIDUAL CAPACITY INCREASED DECREASED 1)Height 1) upright to supine(1 L) 2)Age 2)Inductionanaesthesia0.5L 20% 3)Fibrotic lung diseases 4)women 5)obesity
  • 10.
  • 11. • Closing Capacity:  CC is the sum of closing volume (CV) and RV.  Measurement is by wash in technique with a small bolus of insoluble tracer gas xenon or by nitrogen washout after inspiration of a breath of oxygen from RV.  Normal value-15% to 20% of VC  Increases with age due to loss of structural parenchymal support tissue in the lung and increase in RV.
  • 12. Closing volume:  CV is the lung volume below which small airways begin to close (or at least cease to contribute expiratory gas) during expiration.  Closure of small airways in the basal portions of the lung during deep expiration is a normal phenomenon due to the gravity-dependent increase in pleural pressure at the bases and due to lack of parenchymal support in distal airways.
  • 13. SPIROMETRYPREREQUISITES Do not smoke for at least1hourbefore the test. Do not drink alcohol for at least 4 hours before the test. Do not exercise heavily for at least 30 minutes before the test. Do not wear tight clothing that makes it difficult for you to take a deep breath. Do not eat a large meal within 2 hours before the test.
  • 14. ACCEPTABILITY CRITERIA Good start of test- without any hesitation No Artifact (coughing / glottis closure)  No variable flow  No early termination(> 6 sec)  No air leak REPEATABILITY CRITERIA Two largest FVC within 150 ml of each other Upto 8 manoeuver can be repeated till criteria are met
  • 15. MEASURING FRC ANDRV 18/7/2021 Dr.K.Ha ritha 10
  • 16. 1) N2 WashoutTechnique: patient breathes 100% oxygen all the nitrogen in the lungs is washed out exhaled volume and the nitrogen concentration are measured. nitrogen volume at the initial concentration final exhaled FRC concentration
  • 17. 2)HeliumDilutiontechnique: Pt breathes in and out from a reservoir with known volume of gas containing trace of helium. Helium gets diluted by gas previously present in lungs.
  • 18. 3)BodyPlethysmography Plethysmography (derived from greek word meaning enlargement). Based on principle of BOYLE’S LAW(PV=k) A patient is placed in a sitting position in a closed body box with a known volume The patient pants with an open glottis against a closed shutter to produce changes in the box pressure proportionate to the volume of air in the chest. As measurements done at end of expiration, it yields FRC
  • 19. 14
  • 20. Forced expiratory volume in 1 sec (FEV1): Volume of air that can be forcefully exhaled in 1 sec. Values between 80% and 120% of the predicted value are considered normal. Forced vital capacity (FVC): The volume of air that can be exhaled with maximum effort after a deep inhalation. Normal values are 3.7 L in females and 4.8 L in males. Ratio of FEV1 to FVC: This ratio in healthy adults is 75%–80%. Forced expiratory flow at 25%–75% of vital capacity (FEF25%– 75%): A measurement of airflow through the midpoint of a forced exhalation.
  • 21. Maximum voluntary ventilation (MVV): The maximum amount of air that can be inhaled and exhaled within 1 min. • The volume is measured over a 15-sec time period and results are extrapolated to obtain a value for 1 min expressed as liters per minute. • Average values for males and females are 140–180 and 80–120 L/min, respectively
  • 22. . Diffusing capacity (Dlco): • The volume of a substance [CO] transferred across the alveoli into blood per minute per unit of alveolar partial pressure. • CO is rapidly taken up by hemoglobin and Its transfer is therefore limited mainly by diffusion. • A single breath of 0.3% CO and 10% helium is held for 20 sec. Expired partial pressure of CO is measured. • Normal value is 17–25 mL/min/mm Hg.
  • 23. OBSTRUCTIVE PATTERN Common obstructive lung diseases;  Asthma  COPD (chronic bronchitis, emphysema)
  • 24. RESTRICTIVE PATTERN  Characterized by reduced lung volumes/decreased lung compliance Examples: Interstitial Fibrosis Scoliosis Obesity Lung Resection Neuromuscular diseases
  • 25.
  • 26. FEV1 FVC FEV1/FVC OBSTRUCTIVE DECREASED (<80%) DECREASED DECREASED(< 0.7) RESTRICTIVE DECREASED DECREASED NORMAL OR INCREASED
  • 27. 1) FORCED VITAL CAPACITY Maximum volume of air that can be breathed out as forcefully and rapidly as possible following a maximum inspiration. The expiration should be at least 4 seconds and should not be interrupted by coughing, glottis closure or mechanical obstruction. Normal healthy subjects have VC = FVC. Indirectly reflects flow resistance property of airways. Interpretation of % predicted: >80-120% Normal 70-79% Mild reduction 50%-69% Moderate reduction <50% Severe reduction
  • 28. 2) FORCED EXPIRATORY VOLUME in 1 SEC. (FEV1) Forced expired volume in 1 sec during FVC maneuver. Expressed as an absolute value or % of FVC Normal - FEV1 (1 SEC)- 75-85% OF FVC FEV2 (2 SEC)- 94% OF FVC FEV3 (3 SEC)- 97% OF FVC FEV1 – Decreased in both obstructive & restrictive lung disorders
  • 29.
  • 30.  FEV1%=FEV1/VC X100. • FEV1/FVC – Reduced in obstructive disorders. Interpretation of FEV1 % predicted: >80% Normal 50%-80% Mild obstruction 30%-50% Moderate <30% Severe A FEV1% that is too high is suggestive for a restriction of the pulmonary volume.
  • 31. PULMONARY FUNCTION TESTS Indicate group of studies or maneuvers performed using standardized equipment to measure lung function  Evaluate one or more aspects of the respiratory system Respiratory mechanics Lung parenchymal function/ Gas exchange Cardiopulmonary interaction 15
  • 32. INDICATIONS Investigation of patients with symptoms/signs/ investigations that suggest pulmonary disease e.g.(Cough/Wheeze/Breathlessness/Crackles) Monitoring patients with known pulmonary disease for progression and response to treatment e.g. • Interstitial fibrosis • COPD & Asthma • Pulmonary vascular disease
  • 33. Investigationof patients with disease that may have a respiratory complications e.g. • Connective tissue disorders • Neuromuscular diseases Preoperative evaluation prior to • Lung resection • Abdominal surgery • Cardiothoracic surgery
  • 34. • Evaluation of patients at risk of lungdiseases • Exposure to pulmonary toxins such as radiation,medication,environmental,occupational, exposure • Surveillance following lung transplantation to assess for • 1)Acute rejection • 2)Infection • 3)Obliterative bronchiolitis
  • 35. CONTRAINDICATIONS • Myocardial infarction with in last month • Unstable angina • Recent thoracoabdominal surgery • Recent ophthalmic surgery • Thoracic or abdominal aneurysm • H/o syncope with forced exhalation • Current pneumothorax/hemoptysis
  • 36. INDICATIONS OF PFT IN PAC TISI GUIDELINES FOR PREOPERATIVE SPIROMETRY Age > 70 yrs. Morbid obesity Thoracic surgery Upper abdominal surgery Smoking history and cough Any pulmonary disease
  • 37. American College Of Physicians (ACP) Guidelines For Preoperative Spirometry Lung resection H/o smoking, dyspnoea Cardiac surgery Upper abdominal surgery Lower abdominal surgery Uncharacterized pulmonary disease (defined as history of pulmonary Disease or symptoms and no PFT in last 60 days)
  • 39. 1) SABRASEZ BREATHHOLDING TEST: Ask the patient to take a full but not too deep breath & hold it as long as possible. Assessment of cardio pulmonary reserve >25 SEC - NORMAL Cardiopulmonary Reserve (CPR) 15-25 SEC - LIMITED CPR <15 SEC - VERY POOR CPR (Contraindication for elective surgery)
  • 40. 2) SCHNEIDER’S MATCH BLOWING TEST:Ability of patient to cough &bring out secretions in post operative period or reduction in post op atelectasis Measures Maximum Breathing Capacity Ask to blow a match stick from a distance of 6” (15 cms) with-  Mouth wide open  Chin rested/supported  No purse lipping  No head movement  No air movement in the room  Mouth and match at the samelevel
  • 42. Can’t blow out Able to blow MBC < 60 L/min FEV1 < 1.6L Modified match test: DISTANCE 9” 6” 3” MBC > 60L/min FEV1>1.6L MBC >150 L/MIN. >60 L/MIN. >40 L/MIN
  • 43. 3.COUGH TEST Deep breath inadequate cough if: Followed by cough FVC<20 ml/kg • Ability to cough FEV1<15 ml/kg • Strength PEFR<200L/min • Effectiveness VC-3 Times TV for effective cough
  • 44. 4) FORCED EXPIRATORYTIME: After deep breath, exhale maximally and forcefully & keep stethoscope over trachea& listen. Normal FET – 3-5 SECS. OBS.LUNG DIS. - > 6 SEC RES. LUNG DIS.- < 3 SEC 28
  • 45. 18/7/2021 Dr.K.Ha ritha 29 5)SINGLE BREATHCOUNT: After deep breath, hold it and start counting till the nextbreath. N- 30-40 COUNT Indicates vital capacity
  • 46. 6) WRIGHT PEAK FLOW METER: Measures Peak Expiratory Flow Rate (PEFR) • Normal – males- 450-700 l/min. females- 350-500 l/min.
  • 47. 7) DE-BONO WHISTLE BLOWING TEST: Measures PEFR. Patient blows down a wide bore tube whistle blows leak hole is gradually increased till the till the intensityof whistle disappears. The last position at which the whistle can be blown the PEFR can be read off the scale. ,
  • 48. 8) WRIGHT RESPIROMETER: measures TV, MV  Instrument- compact, light and portable. Can be connected to endotracheal tube or face mask MV- instrument record for 1 min. and read directly TV-calculated by dividing MV by counting Respiratory Rate. Disadvantage: It under- reads at low flow rates and over- reads at high flow rates.
  • 49. 9)SPHYGMOMANOMETER BLOW TEST (endurancetest): -Ask to blow and raise column of Hg upto 40- 50 mmHg and duration is noted. -50 seconds is normal. 10)MICROSPIROMETERS;Measure VC 11) BED SIDE PULSE OXIMETRY 12) ABG.
  • 50. REFERENCES; 1).MILLERS ANAESTHESIA 2).STOELTINGS PHYSIOLOGY AND PHARMACOLOGY 3).STOELTINGS CO-EXISTING DISEASES 34